|Articles|March 1, 2004

Xenical

Roche (Nutley, NJ) recently announcedthat the FDA has approved labeling foruse of the prescription weight-loss medicationXenical (orlistat) in the managementof obese adolescents aged 12 to 16years. This approval offers physicians andparents of overweight and obese adolescentsa safe and effective treatment optionto help manage their weight. Xenicalworks locally in the stomach to preventdietary fat absorption by approximately30%. It helps the patient lose weight aswell as maintain the weight loss. For moreinformation, visit www.xenical.com.

Articles in this issue

over 21 years ago

Article

New Technologies Top Survey

over 21 years ago

Article

PDX Software Gets High Marks

over 21 years ago

Article

Seal•ON

over 21 years ago

Article

SaltAire Sinus Relief

over 21 years ago

Article

Zim's Crack Creme Hand Sanitizer

over 21 years ago

Article

CoroWise Plant Sterols

over 21 years ago

Article

Culturelle

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Latest CME